000 01510 a2200409 4500
005 20250518100420.0
264 0 _c20200713
008 202007s 0 0 eng d
022 _a1878-5832
024 7 _a10.1016/j.drudis.2020.04.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aManning, Thomas J
245 0 0 _aVaporization, bioactive formulations and a marine natural product: different perspectives on antivirals.
_h[electronic resource]
260 _bDrug discovery today
_c06 2020
300 _a956-958 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine Monophosphate
_xadministration & dosage
650 0 4 _aAlanine
_xadministration & dosage
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aAquatic Organisms
_xchemistry
650 0 4 _aBiological Products
_xadministration & dosage
650 0 4 _aCOVID-19
650 0 4 _aChloroquine
_xadministration & dosage
650 0 4 _aCoronavirus Infections
_xdrug therapy
650 0 4 _aDrug Compounding
650 0 4 _aHumans
650 0 4 _aHydroxychloroquine
_xadministration & dosage
650 0 4 _aModels, Molecular
650 0 4 _aPandemics
650 0 4 _aPneumonia, Viral
_xdrug therapy
650 0 4 _aVolatilization
700 1 _aThomas-Richardson, Jenu
700 1 _aCowan, Matthew
700 1 _aBeard, Torien
773 0 _tDrug discovery today
_gvol. 25
_gno. 6
_gp. 956-958
856 4 0 _uhttps://doi.org/10.1016/j.drudis.2020.04.010
_zAvailable from publisher's website
999 _c30891473
_d30891473